

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | toxin transport (GO:1901998) | 9.94537387 |
| 2 | positive regulation of digestive system process (GO:0060456) | 9.75891913 |
| 3 | heart trabecula formation (GO:0060347) | 8.55921383 |
| 4 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 7.18119154 |
| 5 | carnitine transmembrane transport (GO:1902603) | 6.45882207 |
| 6 | regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418) | 6.41156210 |
| 7 | regulation of G0 to G1 transition (GO:0070316) | 6.37890293 |
| 8 | ventricular septum morphogenesis (GO:0060412) | 6.26772484 |
| 9 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 5.93726630 |
| 10 | carnitine transport (GO:0015879) | 5.88446829 |
| 11 | amino-acid betaine transport (GO:0015838) | 5.88446829 |
| 12 | organic cation transport (GO:0015695) | 5.48423200 |
| 13 | establishment of planar polarity (GO:0001736) | 5.33841942 |
| 14 | establishment of tissue polarity (GO:0007164) | 5.33841942 |
| 15 | trabecula formation (GO:0060343) | 5.26301466 |
| 16 | ribosomal small subunit assembly (GO:0000028) | 5.18977372 |
| 17 | negative regulation of chemokine production (GO:0032682) | 5.18485234 |
| 18 | quaternary ammonium group transport (GO:0015697) | 5.15374527 |
| 19 | autophagic vacuole fusion (GO:0000046) | 5.14223341 |
| 20 | rRNA transcription (GO:0009303) | 5.11561231 |
| 21 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 5.05735673 |
| 22 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 5.01464221 |
| 23 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 4.94213651 |
| 24 | negative regulation of mRNA metabolic process (GO:1903312) | 4.85827923 |
| 25 | negative regulation of interleukin-8 production (GO:0032717) | 4.81555155 |
| 26 | negative regulation of nucleotide catabolic process (GO:0030812) | 4.77789661 |
| 27 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 4.69802939 |
| 28 | N-acetylglucosamine metabolic process (GO:0006044) | 4.62737493 |
| 29 | negative regulation of purine nucleotide catabolic process (GO:0033122) | 4.56602434 |
| 30 | drug transmembrane transport (GO:0006855) | 4.54699534 |
| 31 | response to methylmercury (GO:0051597) | 4.50774718 |
| 32 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 4.38868770 |
| 33 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 4.30588668 |
| 34 | regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618) | 4.27475283 |
| 35 | proteoglycan biosynthetic process (GO:0030166) | 4.20060317 |
| 36 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 4.17682234 |
| 37 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 4.16009922 |
| 38 | cellular response to fluid shear stress (GO:0071498) | 4.10066707 |
| 39 | negative regulation of glycogen biosynthetic process (GO:0045719) | 4.06239235 |
| 40 | response to muramyl dipeptide (GO:0032495) | 3.99075635 |
| 41 | regulation of DNA-templated transcription in response to stress (GO:0043620) | 3.88732856 |
| 42 | DNA replication initiation (GO:0006270) | 3.81019237 |
| 43 | organelle membrane fusion (GO:0090174) | 3.78506748 |
| 44 | positive regulation of protein homooligomerization (GO:0032464) | 3.75276116 |
| 45 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.70655127 |
| 46 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 3.70367077 |
| 47 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 3.70367077 |
| 48 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288) | 3.69589417 |
| 49 | drug transport (GO:0015893) | 3.66660369 |
| 50 | gene silencing by RNA (GO:0031047) | 3.66504369 |
| 51 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 3.65536445 |
| 52 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.60469978 |
| 53 | mannosylation (GO:0097502) | 3.60027529 |
| 54 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 3.53468518 |
| 55 | rRNA modification (GO:0000154) | 3.52865919 |
| 56 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.52697045 |
| 57 | regulation of establishment of planar polarity (GO:0090175) | 3.43487210 |
| 58 | histone H3-K9 methylation (GO:0051567) | 3.41170859 |
| 59 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 3.35759731 |
| 60 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 3.35759731 |
| 61 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.31037338 |
| 62 | cornea development in camera-type eye (GO:0061303) | 3.30492325 |
| 63 | response to nitrosative stress (GO:0051409) | 3.28929924 |
| 64 | ether lipid metabolic process (GO:0046485) | 3.28299175 |
| 65 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.28238416 |
| 66 | ncRNA 3-end processing (GO:0043628) | 3.21629871 |
| 67 | negative regulation of cAMP metabolic process (GO:0030815) | 3.18438773 |
| 68 | glucosamine-containing compound metabolic process (GO:1901071) | 3.16557376 |
| 69 | ribosomal small subunit biogenesis (GO:0042274) | 3.15885036 |
| 70 | response to peptidoglycan (GO:0032494) | 3.14837778 |
| 71 | negative regulation of mRNA processing (GO:0050686) | 3.12692214 |
| 72 | negative regulation of glycogen metabolic process (GO:0070874) | 3.12593097 |
| 73 | regulation of skeletal muscle contraction (GO:0014819) | 3.10110400 |
| 74 | negative regulation of cyclic nucleotide metabolic process (GO:0030800) | 3.07094969 |
| 75 | regulation of digestive system process (GO:0044058) | 3.04170269 |
| 76 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.03784266 |
| 77 | cardiac septum morphogenesis (GO:0060411) | 3.03471935 |
| 78 | GDP-mannose metabolic process (GO:0019673) | 3.02584375 |
| 79 | transcription from mitochondrial promoter (GO:0006390) | 3.02468355 |
| 80 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 3.02078296 |
| 81 | negative regulation of RNA splicing (GO:0033119) | 3.01742228 |
| 82 | ribosomal large subunit biogenesis (GO:0042273) | 3.00841658 |
| 83 | histone H3-K9 modification (GO:0061647) | 3.00730707 |
| 84 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.98837877 |
| 85 | DNA double-strand break processing (GO:0000729) | 2.95797915 |
| 86 | centriole assembly (GO:0098534) | 2.95664874 |
| 87 | negative regulation of muscle hypertrophy (GO:0014741) | 2.95274502 |
| 88 | glycoprotein biosynthetic process (GO:0009101) | 2.92143465 |
| 89 | positive regulation of myotube differentiation (GO:0010831) | 2.89460496 |
| 90 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.88462924 |
| 91 | response to laminar fluid shear stress (GO:0034616) | 2.86669584 |
| 92 | purine nucleotide salvage (GO:0032261) | 2.82774259 |
| 93 | erythrocyte development (GO:0048821) | 2.82129347 |
| 94 | viral transcription (GO:0019083) | 2.81632397 |
| 95 | positive regulation of organelle assembly (GO:1902117) | 2.80209237 |
| 96 | labyrinthine layer development (GO:0060711) | 13.1402209 |
| 97 | peptidyl-proline hydroxylation (GO:0019511) | 11.6517843 |
| 98 | response to nitric oxide (GO:0071731) | 11.2160356 |
| 99 | protein hydroxylation (GO:0018126) | 11.0645548 |
| 100 | 4-hydroxyproline metabolic process (GO:0019471) | 10.2942693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 6.56756496 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.24761196 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.91481146 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.70674719 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.38302084 |
| 6 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 3.17847251 |
| 7 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.17008158 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.12279846 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.06959723 |
| 10 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 2.65966948 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.43120110 |
| 12 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.38483833 |
| 13 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 2.28894912 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.10065077 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.06092623 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03566600 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.97441524 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.93925621 |
| 19 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.93287775 |
| 20 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.89179989 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.88481240 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.87824250 |
| 23 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.86015389 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.85293543 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.83143245 |
| 26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.82236458 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.81680098 |
| 28 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.78393809 |
| 29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.77274313 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.76232737 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76020937 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.72460725 |
| 33 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.65965825 |
| 34 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.65181843 |
| 35 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.62635953 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61279440 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.61094864 |
| 38 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.59186308 |
| 39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55744165 |
| 40 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.55426089 |
| 41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.53960221 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53590806 |
| 43 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.49940343 |
| 44 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.49068390 |
| 45 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46163112 |
| 46 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.43054792 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43009008 |
| 48 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.39887630 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38301045 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38143517 |
| 51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32758513 |
| 52 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25255051 |
| 53 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 1.23234807 |
| 54 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.23117851 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22599012 |
| 56 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.20932696 |
| 57 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.18223235 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17992664 |
| 59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.17182451 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.15531646 |
| 61 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.13014998 |
| 62 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.12598636 |
| 63 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.12462364 |
| 64 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.10205058 |
| 65 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.07697572 |
| 66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07678001 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07593175 |
| 68 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07277926 |
| 69 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.05545101 |
| 70 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.05404292 |
| 71 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00181515 |
| 72 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00142209 |
| 73 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97211499 |
| 74 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.96136110 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 0.95610109 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95392516 |
| 77 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95256298 |
| 78 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94769061 |
| 79 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.94721135 |
| 80 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94570523 |
| 81 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.93871795 |
| 82 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93675263 |
| 83 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92665412 |
| 84 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.91732998 |
| 85 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.91732998 |
| 86 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.91317003 |
| 87 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.90040003 |
| 88 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.89170897 |
| 89 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.89170897 |
| 90 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.89170897 |
| 91 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88910358 |
| 92 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.88483014 |
| 93 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.88470960 |
| 94 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.87691368 |
| 95 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.86167551 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85897882 |
| 97 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.83007680 |
| 98 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.80993770 |
| 99 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.80073228 |
| 100 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.79837785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 8.12427347 |
| 2 | MP0002132_abnormal_respiratory_system | 4.25290441 |
| 3 | MP0004484_altered_response_of | 4.17813985 |
| 4 | MP0000383_abnormal_hair_follicle | 4.04085193 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.86568023 |
| 6 | MP0003646_muscle_fatigue | 3.85888610 |
| 7 | MP0001986_abnormal_taste_sensitivity | 3.71262356 |
| 8 | MP0005423_abnormal_somatic_nervous | 3.62445918 |
| 9 | MP0009278_abnormal_bone_marrow | 3.46493405 |
| 10 | MP0005084_abnormal_gallbladder_morpholo | 3.36507597 |
| 11 | MP0001835_abnormal_antigen_presentation | 2.81440737 |
| 12 | MP0010678_abnormal_skin_adnexa | 2.67577265 |
| 13 | MP0001529_abnormal_vocalization | 2.54197293 |
| 14 | MP0003786_premature_aging | 2.40699605 |
| 15 | MP0003123_paternal_imprinting | 2.33682082 |
| 16 | MP0008995_early_reproductive_senescence | 2.29548321 |
| 17 | MP0004233_abnormal_muscle_weight | 2.10998544 |
| 18 | MP0005330_cardiomyopathy | 1.99450406 |
| 19 | MP0003303_peritoneal_inflammation | 1.92134978 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.79750598 |
| 21 | MP0003787_abnormal_imprinting | 1.78924870 |
| 22 | MP0001545_abnormal_hematopoietic_system | 1.55249671 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 1.55249671 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.51839184 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.47992078 |
| 26 | MP0010630_abnormal_cardiac_muscle | 1.45344231 |
| 27 | MP0010368_abnormal_lymphatic_system | 1.40446662 |
| 28 | MP0006035_abnormal_mitochondrial_morpho | 1.37538010 |
| 29 | MP0005076_abnormal_cell_differentiation | 1.36233084 |
| 30 | MP0003077_abnormal_cell_cycle | 1.32955315 |
| 31 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30112025 |
| 32 | MP0003111_abnormal_nucleus_morphology | 1.30074148 |
| 33 | MP0003121_genomic_imprinting | 1.27264521 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.22702582 |
| 35 | MP0002160_abnormal_reproductive_system | 1.19144036 |
| 36 | MP0000490_abnormal_crypts_of | 1.15414958 |
| 37 | MP0000920_abnormal_myelination | 1.15365686 |
| 38 | MP0004147_increased_porphyrin_level | 1.12446525 |
| 39 | MP0008770_decreased_survivor_rate | 1.09937873 |
| 40 | MP0010307_abnormal_tumor_latency | 1.09542393 |
| 41 | MP0000598_abnormal_liver_morphology | 1.07599614 |
| 42 | MP0003567_abnormal_fetal_cardiomyocyte | 1.06210152 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.06206069 |
| 44 | MP0001661_extended_life_span | 1.00613367 |
| 45 | MP0001873_stomach_inflammation | 0.99501940 |
| 46 | MP0002653_abnormal_ependyma_morphology | 0.99289612 |
| 47 | MP0004134_abnormal_chest_morphology | 0.99085032 |
| 48 | MP0003252_abnormal_bile_duct | 0.96303065 |
| 49 | MP0003959_abnormal_lean_body | 0.96255329 |
| 50 | MP0008058_abnormal_DNA_repair | 0.89766640 |
| 51 | MP0005389_reproductive_system_phenotype | 0.87222765 |
| 52 | MP0002822_catalepsy | 0.86944273 |
| 53 | MP0002722_abnormal_immune_system | 0.86742476 |
| 54 | MP0008007_abnormal_cellular_replicative | 0.85569147 |
| 55 | MP0009931_abnormal_skin_appearance | 0.85171417 |
| 56 | MP0001849_ear_inflammation | 0.82521289 |
| 57 | MP0004957_abnormal_blastocyst_morpholog | 0.79059743 |
| 58 | MP0000678_abnormal_parathyroid_gland | 0.77509519 |
| 59 | MP0003315_abnormal_perineum_morphology | 0.76330437 |
| 60 | MP0001544_abnormal_cardiovascular_syste | 0.75464887 |
| 61 | MP0005385_cardiovascular_system_phenoty | 0.75464887 |
| 62 | MP0001440_abnormal_grooming_behavior | 0.74582938 |
| 63 | MP0003718_maternal_effect | 0.74512519 |
| 64 | MP0002127_abnormal_cardiovascular_syste | 0.73793279 |
| 65 | MP0000716_abnormal_immune_system | 0.72025204 |
| 66 | MP0008874_decreased_physiological_sensi | 0.71446940 |
| 67 | MP0008260_abnormal_autophagy | 0.70115913 |
| 68 | MP0006082_CNS_inflammation | 0.68669546 |
| 69 | MP0005085_abnormal_gallbladder_physiolo | 0.68401444 |
| 70 | MP0000477_abnormal_intestine_morphology | 0.67629000 |
| 71 | MP0005025_abnormal_response_to | 0.67420865 |
| 72 | MP0001730_embryonic_growth_arrest | 0.67120566 |
| 73 | MP0003866_abnormal_defecation | 0.66777873 |
| 74 | MP0002083_premature_death | 0.65625271 |
| 75 | MP0000689_abnormal_spleen_morphology | 0.65050078 |
| 76 | MP0002419_abnormal_innate_immunity | 0.63350061 |
| 77 | MP0001919_abnormal_reproductive_system | 0.62813565 |
| 78 | MP0000358_abnormal_cell_content/ | 0.62798430 |
| 79 | MP0002429_abnormal_blood_cell | 0.62707832 |
| 80 | MP0009379_abnormal_foot_pigmentation | 0.62473993 |
| 81 | MP0003942_abnormal_urinary_system | 0.62365635 |
| 82 | MP0002086_abnormal_extraembryonic_tissu | 0.62258623 |
| 83 | MP0000462_abnormal_digestive_system | 0.61864501 |
| 84 | MP0001905_abnormal_dopamine_level | 0.59512770 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 0.58806712 |
| 86 | MP0000703_abnormal_thymus_morphology | 0.56411690 |
| 87 | MP0003880_abnormal_central_pattern | 0.54169510 |
| 88 | MP0000249_abnormal_blood_vessel | 0.52491302 |
| 89 | MP0000266_abnormal_heart_morphology | 0.52438349 |
| 90 | MP0004036_abnormal_muscle_relaxation | 0.52374525 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.51243291 |
| 92 | MP0003984_embryonic_growth_retardation | 0.49922953 |
| 93 | MP0002420_abnormal_adaptive_immunity | 0.49894289 |
| 94 | MP0004808_abnormal_hematopoietic_stem | 0.49686488 |
| 95 | MP0001819_abnormal_immune_cell | 0.49651364 |
| 96 | MP0003948_abnormal_gas_homeostasis | 0.49595655 |
| 97 | MP0005380_embryogenesis_phenotype | 0.48899513 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 0.48899513 |
| 99 | MP0001853_heart_inflammation | 0.48728871 |
| 100 | MP0002398_abnormal_bone_marrow | 0.48663065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Onycholysis (HP:0001806) | 7.02214750 |
| 2 | Loss of speech (HP:0002371) | 5.60110210 |
| 3 | Confusion (HP:0001289) | 5.56299654 |
| 4 | Cerebellar dysplasia (HP:0007033) | 4.76734979 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 4.62559046 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.56579133 |
| 7 | Partial agenesis of the corpus callosum (HP:0001338) | 4.38382072 |
| 8 | Abnormality of urine glucose concentration (HP:0011016) | 4.09104293 |
| 9 | Glycosuria (HP:0003076) | 4.09104293 |
| 10 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.08983477 |
| 11 | Stomatitis (HP:0010280) | 4.06925681 |
| 12 | Bulbar palsy (HP:0001283) | 3.87896227 |
| 13 | Patent foramen ovale (HP:0001655) | 3.82196671 |
| 14 | Type I transferrin isoform profile (HP:0003642) | 3.77824330 |
| 15 | Abnormal gallbladder physiology (HP:0012438) | 3.72121155 |
| 16 | Cholecystitis (HP:0001082) | 3.72121155 |
| 17 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.62712814 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.57251098 |
| 19 | Visual hallucinations (HP:0002367) | 3.53059705 |
| 20 | Hyperammonemia (HP:0001987) | 3.32044003 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.29439595 |
| 22 | Abnormality of alanine metabolism (HP:0010916) | 3.27218734 |
| 23 | Hyperalaninemia (HP:0003348) | 3.27218734 |
| 24 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.27218734 |
| 25 | Thrombocytosis (HP:0001894) | 3.22626098 |
| 26 | Hypercortisolism (HP:0001578) | 3.21997268 |
| 27 | Pseudobulbar signs (HP:0002200) | 3.21413227 |
| 28 | Abnormal protein glycosylation (HP:0012346) | 3.18398297 |
| 29 | Abnormal glycosylation (HP:0012345) | 3.18398297 |
| 30 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.18398297 |
| 31 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.18398297 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.11063896 |
| 33 | Myopathic facies (HP:0002058) | 2.97186914 |
| 34 | Episodic fever (HP:0001954) | 2.96485682 |
| 35 | Increased CSF protein (HP:0002922) | 2.83731021 |
| 36 | Male infertility (HP:0003251) | 2.79214691 |
| 37 | Hypoglycemic seizures (HP:0002173) | 2.74826214 |
| 38 | Lower limb hyperreflexia (HP:0002395) | 2.74297109 |
| 39 | Heterotopia (HP:0002282) | 2.72944317 |
| 40 | Amyloidosis (HP:0011034) | 2.69597797 |
| 41 | Cardiomegaly (HP:0001640) | 2.67259220 |
| 42 | Abnormality of the vocal cords (HP:0008777) | 2.64620748 |
| 43 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.63663784 |
| 44 | Increased intramyocellular lipid droplets (HP:0012240) | 2.62249481 |
| 45 | Severe visual impairment (HP:0001141) | 2.57197348 |
| 46 | Double outlet right ventricle (HP:0001719) | 2.54382222 |
| 47 | Congenital malformation of the right heart (HP:0011723) | 2.54382222 |
| 48 | Lipid accumulation in hepatocytes (HP:0006561) | 2.53664038 |
| 49 | Broad distal phalanx of finger (HP:0009836) | 2.52967120 |
| 50 | Hypoplasia of the uterus (HP:0000013) | 2.48941649 |
| 51 | Increased hepatocellular lipid droplets (HP:0006565) | 2.47567265 |
| 52 | Increased muscle lipid content (HP:0009058) | 2.45578477 |
| 53 | Neurofibrillary tangles (HP:0002185) | 2.43811123 |
| 54 | Ankle contracture (HP:0006466) | 2.40830300 |
| 55 | Tinnitus (HP:0000360) | 2.39537770 |
| 56 | Peripheral demyelination (HP:0011096) | 2.38441183 |
| 57 | Exertional dyspnea (HP:0002875) | 2.32328058 |
| 58 | Renal Fanconi syndrome (HP:0001994) | 2.31150729 |
| 59 | Nephronophthisis (HP:0000090) | 2.30843185 |
| 60 | Increased IgE level (HP:0003212) | 2.26159284 |
| 61 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.23587346 |
| 62 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.23587346 |
| 63 | Single umbilical artery (HP:0001195) | 2.23587346 |
| 64 | Neurodegeneration (HP:0002180) | 2.22865289 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.22375434 |
| 66 | Rhabdomyolysis (HP:0003201) | 2.20748868 |
| 67 | Tetraplegia (HP:0002445) | 2.20203851 |
| 68 | Flat face (HP:0012368) | 2.17194147 |
| 69 | EMG: neuropathic changes (HP:0003445) | 2.10283737 |
| 70 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.08175260 |
| 71 | Abnormal hemoglobin (HP:0011902) | 2.06837621 |
| 72 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.05155447 |
| 73 | Obstructive lung disease (HP:0006536) | 2.03654106 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03654106 |
| 75 | Microretrognathia (HP:0000308) | 2.03041867 |
| 76 | Abnormality of B cell number (HP:0010975) | 2.01894886 |
| 77 | Agnosia (HP:0010524) | 2.00986654 |
| 78 | Polycythemia (HP:0001901) | 10.3176505 |
| 79 | Hypochromic anemia (HP:0001931) | 1.98096242 |
| 80 | Multiple enchondromatosis (HP:0005701) | 1.96030684 |
| 81 | Right ventricular cardiomyopathy (HP:0011663) | 1.94181984 |
| 82 | Mask-like facies (HP:0000298) | 1.93061083 |
| 83 | Delusions (HP:0000746) | 1.92724971 |
| 84 | Polyneuropathy (HP:0001271) | 1.87938504 |
| 85 | Abnormality of the endocardium (HP:0004306) | 1.82917897 |
| 86 | True hermaphroditism (HP:0010459) | 1.78168637 |
| 87 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77576081 |
| 88 | Palpitations (HP:0001962) | 1.76753836 |
| 89 | Central scotoma (HP:0000603) | 1.76531940 |
| 90 | B lymphocytopenia (HP:0010976) | 1.74786585 |
| 91 | Ependymoma (HP:0002888) | 1.71832210 |
| 92 | Symptomatic seizures (HP:0011145) | 1.69046393 |
| 93 | Broad thumb (HP:0011304) | 1.69028590 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 1.68478924 |
| 95 | Ileus (HP:0002595) | 1.68331687 |
| 96 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.66800418 |
| 97 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.65986762 |
| 98 | Abnormal platelet volume (HP:0011876) | 1.64764503 |
| 99 | Palpebral edema (HP:0100540) | 1.64677191 |
| 100 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.62166526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 9.51015050 |
| 2 | TAOK3 | 6.82431330 |
| 3 | SCYL2 | 5.06717054 |
| 4 | MAP3K6 | 4.65099717 |
| 5 | MAP2K3 | 3.88081358 |
| 6 | BCKDK | 2.86139659 |
| 7 | MAPK7 | 2.71363915 |
| 8 | PLK4 | 2.51521674 |
| 9 | RET | 1.88947528 |
| 10 | MAP2K4 | 1.82164124 |
| 11 | MAP2K6 | 1.79059501 |
| 12 | MAP3K5 | 1.71156684 |
| 13 | TXK | 1.67406147 |
| 14 | ZAP70 | 1.50899611 |
| 15 | BMPR2 | 1.32638964 |
| 16 | BRSK2 | 1.18138051 |
| 17 | TESK2 | 1.11999803 |
| 18 | MAP4K1 | 1.10346540 |
| 19 | STK16 | 1.03021221 |
| 20 | PLK2 | 0.95980016 |
| 21 | TYK2 | 0.94115122 |
| 22 | STK38L | 0.82330684 |
| 23 | NME2 | 0.80513709 |
| 24 | MINK1 | 0.78625869 |
| 25 | TNK2 | 0.75622966 |
| 26 | MAP3K1 | 0.72287126 |
| 27 | CDK3 | 0.71816766 |
| 28 | ZAK | 0.71702661 |
| 29 | RPS6KB1 | 0.64888831 |
| 30 | JAK3 | 0.64880613 |
| 31 | CDK12 | 0.62356560 |
| 32 | PRKD3 | 0.60789824 |
| 33 | BRSK1 | 0.59530877 |
| 34 | TBK1 | 0.57820730 |
| 35 | SGK3 | 0.56728025 |
| 36 | PASK | 0.55186129 |
| 37 | CDK19 | 0.54844962 |
| 38 | RPS6KB2 | 0.54195791 |
| 39 | IKBKB | 0.53700137 |
| 40 | ABL2 | 0.53543629 |
| 41 | PRKCH | 0.52974238 |
| 42 | PRPF4B | 0.52772896 |
| 43 | MARK3 | 0.52351332 |
| 44 | PTK2 | 0.50416408 |
| 45 | GRK1 | 0.49488911 |
| 46 | NEK9 | 0.49396289 |
| 47 | WEE1 | 0.48084246 |
| 48 | MAP3K3 | 0.47756326 |
| 49 | KIT | 0.45968514 |
| 50 | AURKA | 0.41415738 |
| 51 | RPS6KC1 | 0.40854096 |
| 52 | RPS6KL1 | 0.40854096 |
| 53 | KDR | 0.40377754 |
| 54 | GRK7 | 0.39098567 |
| 55 | BTK | 0.38930536 |
| 56 | SGK2 | 0.38788693 |
| 57 | AKT2 | 0.36241689 |
| 58 | ADRBK1 | 0.36186590 |
| 59 | PIM1 | 0.36155212 |
| 60 | BUB1 | 0.34407031 |
| 61 | RPS6KA6 | 0.33367369 |
| 62 | RPS6KA1 | 0.32548895 |
| 63 | IRAK3 | 0.30050290 |
| 64 | MAPK12 | 0.29452345 |
| 65 | MTOR | 0.28001101 |
| 66 | LYN | 0.27596350 |
| 67 | LCK | 0.26173058 |
| 68 | IKBKE | 0.25061730 |
| 69 | MAP3K4 | 0.23700516 |
| 70 | MARK2 | 0.21889174 |
| 71 | CDK8 | 0.21515187 |
| 72 | PRKACG | 0.19430430 |
| 73 | STK4 | 0.19356615 |
| 74 | STK10 | 0.19241755 |
| 75 | AKT1 | 0.18357466 |
| 76 | PRKCB | 0.18193911 |
| 77 | MAP2K7 | 0.16917938 |
| 78 | PRKCQ | 0.16672252 |
| 79 | MAPK13 | 0.16310358 |
| 80 | PLK1 | 0.16061512 |
| 81 | GRK6 | 0.15797631 |
| 82 | MAPK11 | 0.15784352 |
| 83 | FLT3 | 0.15508493 |
| 84 | BMX | 0.15251195 |
| 85 | EPHA4 | 0.14351690 |
| 86 | CSNK2A2 | 0.13901934 |
| 87 | PRKG2 | 0.13698831 |
| 88 | PRKCE | 0.13376508 |
| 89 | PDPK1 | 0.12989954 |
| 90 | CHEK2 | 0.12779165 |
| 91 | PIK3CG | 0.12397341 |
| 92 | PDK1 | 0.12046277 |
| 93 | FES | 0.11982518 |
| 94 | GSK3A | 0.11928188 |
| 95 | HCK | 0.11515939 |
| 96 | PAK2 | 0.10494889 |
| 97 | CSNK2A1 | 0.10330813 |
| 98 | MOS | 0.10165762 |
| 99 | MATK | 0.10150888 |
| 100 | SYK | 0.09749706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 6.58799544 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.22264134 |
| 3 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 3.55850466 |
| 4 | RNA degradation_Homo sapiens_hsa03018 | 3.47516588 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 3.28089740 |
| 6 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.74492377 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.61231588 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.47080342 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 2.08979494 |
| 10 | Renal cell carcinoma_Homo sapiens_hsa05211 | 2.06081996 |
| 11 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.97123239 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 1.94411467 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.85870862 |
| 14 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.75958483 |
| 15 | RNA transport_Homo sapiens_hsa03013 | 1.75012756 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68248538 |
| 17 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.64549593 |
| 18 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.53514998 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.53235145 |
| 20 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52522386 |
| 21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41048171 |
| 22 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.25801779 |
| 23 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23719643 |
| 24 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20363111 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.20134330 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12106271 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.09102228 |
| 28 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.07998544 |
| 29 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.07034559 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 1.05356637 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03683205 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.02704316 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.00860325 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.00320872 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97133072 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.96166495 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95487130 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94696148 |
| 39 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94625468 |
| 40 | Lysosome_Homo sapiens_hsa04142 | 0.93491569 |
| 41 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.91504427 |
| 42 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.87984833 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 0.87249939 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 0.85921701 |
| 45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.82555596 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79310199 |
| 47 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77383090 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.77122857 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 0.76711845 |
| 50 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76005013 |
| 51 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.70427064 |
| 52 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68063148 |
| 53 | Taste transduction_Homo sapiens_hsa04742 | 0.67351475 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.65011263 |
| 55 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63910281 |
| 56 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.62714724 |
| 57 | Pertussis_Homo sapiens_hsa05133 | 0.60872319 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58865019 |
| 59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57024138 |
| 60 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54231411 |
| 61 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.53688415 |
| 62 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.52373485 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52306918 |
| 64 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51846815 |
| 65 | Purine metabolism_Homo sapiens_hsa00230 | 0.50280724 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50167414 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48274310 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44157192 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43810904 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43432429 |
| 71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43353422 |
| 72 | Melanogenesis_Homo sapiens_hsa04916 | 0.42871875 |
| 73 | Legionellosis_Homo sapiens_hsa05134 | 0.42850500 |
| 74 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41628633 |
| 75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.39560183 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38776249 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37001718 |
| 78 | Influenza A_Homo sapiens_hsa05164 | 0.34806698 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33961976 |
| 80 | Pathways in cancer_Homo sapiens_hsa05200 | 0.33469626 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33397714 |
| 82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32730265 |
| 83 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32461415 |
| 84 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32156457 |
| 85 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.32049116 |
| 86 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.29967762 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.29512627 |
| 88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24440956 |
| 89 | Mismatch repair_Homo sapiens_hsa03430 | 0.20101134 |
| 90 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17619045 |
| 91 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17186078 |
| 92 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17010898 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.16537061 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.15889096 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.14930105 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.13964800 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.13708569 |
| 98 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.13168292 |
| 99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13158714 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12515956 |

